Wright Medical Group (WMGI) Stock Price, News & Analysis

Company Overview

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.

Key Stats

• Today's Range: $29.98 to $29.98
• 50-Day Range: $29.98 to $30.72
• 52-Week Range: $23.14 to $30.74
• Volume: 9,689 shs
• Average Volume: 2.02 million shs
• Market Capitalization: $3.90 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WMGI Stock Analysis - Frequently Asked Questions

How were Wright Medical Group's earnings last quarter?

Wright Medical Group (NASDAQ:WMGI) issued its quarterly earnings data on Wednesday, August, 8th. The medical device company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The firm's revenue was up 14.3% compared to the same quarter last year.

What other stocks do shareholders of Wright Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Wright Medical Group investors own include Gilead Sciences (GILD), Bristol Myers Squibb (BMY), AbbVie (ABBV), Exelixis (EXEL), Walt Disney (DIS), NVIDIA (NVDA) and Regeneron Pharmaceuticals (REGN).

Company Calendar

• Last Earnings: 8/08/2018
• Today: 7/02/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical Appliances & Supplies
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:WMGI
• CIK: 1492658
• Web: www.wright.com
• Phone: 31-20-521-4777
• Fax: N/A
• Employees: 3,030
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.06
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 68.14
• P/E Growth: 6.37
• Net Income: -$114.22 million
• Net Margins: -16.59%
• Pretax Margin: N/A
• Return on Equity: -3.86%
• Return on Assets: -1.32%

Debt

• Debt-to-Equity Ratio: 0.90
• Current Ratio: 0.82
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $920.90 million
• Price / Sales: 4.23
• Cash Flow: $1.23 per share
• Price / Cash Flow: 24.31
• Book Value: $7.03 per share
• Price / Book: 4.26

Miscellaneous

• Outstanding Shares: 129,935,000
• Free Float: N/A
• Market Cap: $3.90 billion
• Optionable: Optionable
• Beta: 0.57